These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2328158)

  • 1. 3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeys.
    Boudinot FD; Schinazi RF; Gallo JM; McClure HM; Anderson DC; Doshi KJ; Kambhampathi PC; Chu CK
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):219-28. PubMed ID: 2328158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
    Doshi KJ; Gallo JM; Boudinot FD; Schinazi RF; Chu CK
    Drug Metab Dispos; 1989; 17(6):590-4. PubMed ID: 2575492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
    Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
    J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
    Manouilov KK; White CA; Boudinot FD; Fedorov II; Chu CK
    Drug Metab Dispos; 1995 Jun; 23(6):655-8. PubMed ID: 7587948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of 3'-azido-2', 3'-dideoxyuridine-5'-O-valinate-hydrochloride as a prodrug of the anti-HIV nucleoside 3'-azido-2', 3'-dideoxyuridine.
    Kong L; Cooperwood JS; Huang SH; Chu CK; Boudinot FD
    Antivir Chem Chemother; 2003 Sep; 14(5):263-70. PubMed ID: 14694989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
    Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
    Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
    J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
    Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
    J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. VI. Effect of the calcium channel blocker nimodipine on zidovudine kinetics in monkeys.
    Gallo JM; Swagler AR; Mehta M; Qian M
    J Pharmacol Exp Ther; 1993 Jan; 264(1):315-20. PubMed ID: 8423534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid pharmacokinetic models to describe anti-HIV nucleoside brain disposition following parent and prodrug administration in mice.
    Gallo JM; Etse JT; Doshi KJ; Boudinot FD; Chu CK
    Pharm Res; 1991 Feb; 8(2):247-53. PubMed ID: 2023876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.
    Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP
    Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion.
    Patterson TA; Binienda ZK; Lipe GW; Gillam MP; Slikker W; Sandberg JA
    Drug Metab Dispos; 1997 Apr; 25(4):453-9. PubMed ID: 9107545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of 3'-azido-3'-deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose.
    Poirier MC; Patterson TA; Slikker W; Olivero OA
    J Acquir Immune Defic Syndr; 1999 Dec; 22(5):477-83. PubMed ID: 10961609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys.
    Schinazi RF; Boudinot FD; Doshi KJ; McClure HM
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1214-9. PubMed ID: 2168144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of 3'-azido-3'-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase. Significance of nucleoside hydrophobicity and inhibition by xenobiotics.
    Resetar A; Minick D; Spector T
    Biochem Pharmacol; 1991 Jul; 42(3):559-68. PubMed ID: 1907149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catabolic disposition of 3'-azido-2',3'-dideoxyuridine in hepatocytes with evidence of azido reduction being a general catabolic pathway of 3'-azido-2',3'-dideoxynucleosides.
    Cretton EM; Xie MY; Goudgaon NM; Schinazi RF; Chu CK; Sommadossi JP
    Biochem Pharmacol; 1992 Sep; 44(5):973-80. PubMed ID: 1326966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate.
    Song H; Johns R; Griesgraber GW; Wagner CR; Zimmerman CL
    Pharm Res; 2003 Mar; 20(3):448-51. PubMed ID: 12669967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical reduction products of azido nucleosides, including zidovudine (AZT): mechanisms and relevance to their intracellular metabolism.
    Kawczyński W; Czochralska B; Shugar D
    Acta Biochim Pol; 1993; 40(2):213-23. PubMed ID: 8212958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Existence of a flip-flop kinetic model for zidovudine (AZT) after oral administration.
    Melvin GC; Ellison SR; Monk CM; Bates TR
    Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):193-204. PubMed ID: 2277865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.